Peter Attia· MD
what's really interesting here is when you look at the insulin response under the intravenous glucose administration you see it's a fraction of what is delivered or appreciated in the oral glucose administration
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
what's really interesting here is when you look at the insulin response under the intravenous glucose administration you see it's a fraction of what is delivered or appreciated in the oral glucose administration
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
you see with the oral glucose administration the attenuation of glucagon is less than with the intravenous administration so again that delta is referred to here as the incretin effect
what explains that difference well that difference which is basically the shaded green area is referred to as the incretin effect